The Research Team at the Ragon Institute of Mass General, MIT, and Harvard is dedicated to pioneering the discovery of an HIV/AIDS vaccine through a multidisciplinary approach. This diverse group, comprising senior scientists, postdoctoral fellows, research scholars, technologists, and technicians, engages in cutting-edge immunological research. They integrate complex areas of vaccine development, pursue innovative and high-risk studies with rapidly accessible funding, and foster collaborations among expert scientists, engineers, and clinicians to expedite bench-to-bedside research, ultimately working toward saving lives and eradicating diseases.